Thermo Fisher Scientific (TMO) Tops Q1 EPS by 40c, raises guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Thermo Fisher Scientific (TMO) PT Raised to $610 at Deutsche Bank
April 25, 2024 6:16 AM EDTDeutsche Bank analyst Justin Bowers raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $610.00 (from $600.00) while maintaining a Buy rating.
The analyst comments "Messaging around bioprocessing was concise but positive, as order growth and book-to-bill continue to trend higher. We are... More
Thermo Fisher Scientific (TMO) lifts guidance after topping Q1 expectations
April 24, 2024 6:13 AM EDTThermo Fisher Scientific (NYSE: TMO) shares rose 3.55% after the company reported first-quarter earnings and revenue that exceeded Wall Street's expectations. The company's adjusted earnings per share (EPS) came in at $5.11, surpassing the analyst estimate of $4.71. Revenue for the quarter also beat consensus estimates, reaching $10.34 billion against expectations of $10.16 billion.
The science-serving leader saw a slight decline in revenue compared to the... More
